DONALD PIESTRAK: Open Payments
NPI 1588093587 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,672 in 87 payments from 16 companies in 2025. Trend: 2023 $613 · 2024 $1,590 · 2025 $1,672
Food & beverage: $1,672
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $420 |
| AstraZeneca Pharmaceuticals LP | 15 | $301 |
| ABBVIE INC. | 13 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $131 |
| Amgen Inc. | 6 | $102 |
| Axsome Therapeutics, Inc. | 5 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $56 |
Products named: ELIQUIS, NURTEC ODT, AIRSUPRA, CAPLYTA, VRAYLAR, JARDIANCE, BREZTRI, REXULTI.
Industry payments across GA — which companies pay providers there.
